Insulet (STU:GOV) Other Gross PPE : €614 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Insulet Other Gross PPE?

Insulet's Other Gross PPE for the quarter that ended in Mar. 2024 was €614 Mil.

Insulet's quarterly Other Gross PPE declined from Sep. 2023 (€608 Mil) to Dec. 2023 (€15 Mil) but then increased from Dec. 2023 (€15 Mil) to Mar. 2024 (€614 Mil).

Insulet's annual Other Gross PPE increased from Dec. 2021 (€5 Mil) to Dec. 2022 (€11 Mil) and increased from Dec. 2022 (€11 Mil) to Dec. 2023 (€15 Mil).

Insulet Other Gross PPE Historical Data

The historical data trend for Insulet's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Insulet Other Gross PPE Chart

Insulet Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Gross PPE

Get a 7-Day Free Trial

1.44

3.62

5.22

11.04

14.67

Insulet Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Gross PPE	Get a 7-Day Free Trial															557.22	555.19	608.30	14.67	614.28

Insulet Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Insulet (STU:GOV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Insulet Corp (STU:GOV) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

PODD:USA PODD:Mexico GOV:Germany

Address

100 Nagog Park, Acton, MA, USA, 01720

Website

https://www.insulet.com

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 360,000 insulin-dependent diabetics are using it worldwide.

Insulet (STU:GOV) Headlines

No Headlines